Lerner, Seth P.
Article History
First Online: 5 July 2016
Competing interests
: S.L. has worked with BioCancell, Vaxxion Therapeutics, UroGen Pharma, Telesta Therapeutics, Sitka Biopharma, Neucleixx, Taris Biomedical, Ferring Pharmaceuticals and the Bladder Cancer Journal. He has received grants from ENDO Intenational, FKD Therapies, Viventia Bio, Roche, Genentech and Genome DX.